Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Furthermore, a clinical phase II trial (NCT03057600) is conducted to evaluate the combination of CB-839 and paclitaxel to treat TNBC (Shen et al., 2021)
Editor CatalA
Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
Antioxidant Support: Alpha Lipoic Acid is a potent antioxidant that fights inflammation and oxidative stress in the skin
Safety Studies and Toxicity Data Studies evaluating GHK-CU have consistently shown minimal toxicity and a high safety margin in various concentrations
US$ 21.62
US$ 25.82
US$ 22.38
US$ 23.95
US$ 25.31
